CLINICAL-GRADE WHOLE GENOME SEQUENCING TEST
The most complete genomic solution to provide the highest likelihood of finding a diagnosis for rare disease.
Whole Genome Sequencing is the only genetic test that can decipher the entire human DNA (100% of DNA). Dante Genomics offers 30X coverage, meaning the entire genome will be analyzed 30 times, picking up more valuable genomic information with each pass.
Dante Genomics’ Whole Genome Sequencing Test is a test for everyone. For people facing rare or undiagnosed diseases, still more! We solve complex genetic cases by combining phenotypic data and genomic data from 100% of human DNA.
Whole Genome Sequencing enables greater and more precise diagnostic yield for rare disease
Next-Generation Sequencing (NGS) Whole Genome Sequencing Test is the most powerful tool to help rare disease patients end years of hospital visits and expensive tests.
Rare Disease in numbers
- 80% of rare diseases have a genomic component.
- 50% of new cases are found in children.
- +150 million people worldwide are affected by a rare disease.
- On average, the rare disease diagnosis journey, so called “diagnostic odyssey” takes 5-7 years, 4-8 physicians, 2-3 misdiagnoses.
Tell us about your story, needs, or doubts.
Please complete the contact form to connect with the Dante Team. An expert will answer your request.
Dante Genomics is a leading global genomics and precision medicine company working to accelerate science to deliver better healthcare and ultimately save lives with a more human approach to health.